Register now to learn about a new option for relapsed or refractory follicular lymphoma

Where New Updates in Genitourinary Cancer Continue to Come From

MICHAEL LAI, ARNP | September 05, 2019

In the genitourinary cancer space, there have been a lot of updates to follow in the past 5 years. At the 3rd Annual School of Nursing Oncology, we spoke with Michael Lai, ARNP, a nurse practitioner at Seattle Cancer Care Alliance, about why he thinks there have been so many updates recently.

I think that it's sort of a coalescence of a number of different things, timing, maybe a little bit of luck, and there's just a lot more interest in bladder cancer these days. It's a deadly disease when it's metastatic, and we're trying to find options that go beyond the first and second line that can really prove to have some survival benefit. For prostate cancer, it's such a common ubiquitous disease amongst men, and so, it just makes sense to continue the research in this realm and provide all the options that we can. 

External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.